Infección del torrente sanguíneo por Candida glabrata en una unidad de cuidados intensivos neonatales con prescripción de profilaxis con fluconazol

Ascher, 2012, Antifungal therapy and outcomes in infants with invasive Candida infections, Pediatr Infect Dis J., 31, 439, 10.1097/INF.0b013e3182467a72 Auron, 2009, Effect of amphotericin B lipid complex (ABLC) in very low birth weight infants, Pediatr Nephrol., 24, 295, 10.1007/s00467-008-1017-5 Beyer, 2019, Antifungal susceptibility of yeast bloodstream isolates collected during a 10-year period in Austria, Mycoses., 62, 357, 10.1111/myc.12892 Castagnola, 2009, Combined antifungal therapy for persistent central venous catheter-related candidemia in extremely low birth weight neonates, J Chemother., 21, 234, 10.1179/joc.2009.21.2.234 Clerihew, 2012, Antifungal therapy for newborn infants with invasive fungal infection, Cochrane Database Syst Rev., CD003953 Consejo de Salubridad General. Prevención, diagnóstico y tratamiento de sepsis y choque séptico del recién nacido en el segundo y tercer nivel de atención. México: Secretaria de Salud; [Documento en línea] 2012 [consultado Mar 2018]. Disponible en: http://www.cenetec.salud.gob.mx/descargas/gpc/CatalogoMaestro/283_GPC_SepsisNeonatal/SS-283-12_RER_SEPSIS_Y_CHOQUE_SxPTICO_RN.pdf Fairchild, 2002, Neonatal Candida glabrata sepsis: clinical and laboratory features compared with other Candida species, Pediatr Infect Dis J., 21, 39, 10.1097/00006454-200201000-00009 Jeon, 2014, Successful caspofungin treatment of persistent candidemia in extreme prematurity at 23 and 24 weeks’ gestation, J Formos Med Assoc., 113, 191, 10.1016/j.jfma.2014.01.003 Malani, 2005, Candida glabrata fungemia: experience in a tertiary care center, Clin Infect Dis., 41, 975, 10.1086/432939 Mohan, 2019, Epidemiology and risk factors for Candida infection in neonates, Weisman ed. UpToDate. [Documento en línea] Pappas, 2016, Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America, Clin Infect Dis., 62, e1, 10.1093/cid/civ933 Rodrigues, 2014, Candida glabrata: a review of its features and resistance, Eur J Clin Microbiol Infect Dis., 33, 673, 10.1007/s10096-013-2009-3 Safdar, 2002, Antimicrob Agents Chemother., 46, 3268, 10.1128/AAC.46.10.3268-3272.2002 Santolaya, 2013, Recommendations for the management of candidemia in neonates in Latin America. Grupo Proyecto Épico, Rev Iberoam Micol., 30, 158 Turkova, 2011, Amphotericin B in neonates: deoxycholate or lipid formulation as first-line therapy - is there a ‘right’ choice?, Curr Opin Infect Dis., 24, 163, 10.1097/QCO.0b013e328343614e Würthwein, 2005, Population pharmacokinetics of amphotericin B lipid complex in neonates, Antimicrob Agents Chemother., 49, 5092, 10.1128/AAC.49.12.5092-5098.2005